NCT06430762 Therapeutic Exposures and Risk Factors in MRONJ
| NCT ID | NCT06430762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Medication-Related Osteonecrosis of Jaw |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-04-25 |
| Primary Completion | 2026-04-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-04-25 with a primary completion date of 2026-04-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.
Eligibility Criteria
Inclusion Criteria: * Individuals aged 18 and over * Male or female individuals * Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period * Individuals or their legal representatives who have given written consent to participate in the study Exclusion Criteria: * Non-drug-related osteonecrosis/osteomyelitis * Osteoradionecrosis * Metastasis to the oral region * Individuals who have not given written consent to participate in the study * Individuals under the age of 18
Contact & Investigator
Ferit Bayram, PhD
STUDY CHAIR
Marmara University Faculty of Dentistry
Frequently Asked Questions
Who can join the NCT06430762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Medication-Related Osteonecrosis of Jaw. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06430762 currently recruiting?
Yes, NCT06430762 is actively recruiting participants. Contact the research team at ferit.bayram@marmara.edu.tr for enrollment information.
Where is the NCT06430762 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06430762 clinical trial?
NCT06430762 is sponsored by Marmara University. The principal investigator is Ferit Bayram, PhD at Marmara University Faculty of Dentistry. The trial plans to enroll 250 participants.